3D生物打印技术的应用不仅可以极大的提高国民健康水平,更是增强国家核心竞争力的战略选择.文章基于SAO结构分析方法对3D生物打印技术的应用领域进行识别,并进一步分析各应用领域的发展态势,通过专利计量方法甄别3D生物打印技术合适的国际合作伙伴.研究结果表明3D生物打印技术的应用可分为四个层次七大应用领域,现阶段中国机构应着力提高人体细胞、人体内脏器官等应用领域研发水平,目前该层次最合适的国际合作伙伴为美国ORGANOVO公司.分析结论将为我国3D生物打印产业的未来发展提供有用信息,并为构建新时期国际合作战略、更好地适应"十三五"国际科技合作面临的形势和需求提供决策支持.%The application of 3D bioprinting technology can not only greatly improve the health of citizens,but also be the national strategic choice to enhance the core competitiveness.This study identified the application fields of 3D bioprinting technology based on the SAO structural analysis method and presented a longitudinal analysis of development trend of various application fields.Furthermore,this article identified the appropriate international partners through patent bibliometrics analysis.The result shows that the application of 3D bioprinting technology can be divided into four levels,seven application fields.Chinese institutions should focus on improving R&D level of human cells,human internal organs and other applications fields and the most appropriate international partner is American company ORGANOVO at present.The conclusions will provide useful information for the future development of China's 3D bioprinting industryand make decisions for the international cooperation strategy.
展开▼
